We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App





AI-Powered Smart COVID-19 Eyewear Tracks Wearer’s Biometrics to Measure Risk of Contracting Coronavirus

By HospiMedica International staff writers
Posted on 14 Sep 2020
Scientists have developed smart COVID-19 eyewear that measures the user’s risk of potentially contracting the novel coronavirus and advice subsequent actions.

IP Venture, Inc. More...
(San Jose, CA, USA), together with its affiliate company IngenioSpec, is offering smart COVID-19 eyewear that can track a user’s biometrics - such as heart rate, oxygen level, temperature, activity level, and coughing frequency - and provide alert if someone approaching has a high temperature, or has been infected via available contact-tracing programs. By keeping track of the different factors and based on COVID’s signature, the eyewear can better identify the risk of a person getting the virus and can prompt him to consider self-quarantine and schedule for a test ASAP. Knowing if one is positive even a few days earlier can prove vital in fighting the spread of this pandemic.

For those inflicted with the virus, a digital assistant in the eyewear can provide gentle reminders, such as to regularly hydrate; moral support, such as playing a favorite song; or official recommendations, like how many days the user’s family should remain isolated. Through continual monitoring, the eyewear could contact or suggest contacting medical personnel if the user’s condition worsens. For those with “long haul” COVID-19, the eyewear could keep track of a patient’s long-term biometrics to better understand the virus and hopefully find effective treatment.

Related Links:
IP Venture, Inc.


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.